NEUVENGE

Serial Number 85657232
606

Registration Progress

Application Filed
Jun 20, 2012
Under Examination
Jan 8, 2013
Approved for Publication
Nov 13, 2012
Published for Opposition
Nov 13, 2012
Registered

Trademark Image

NEUVENGE

Basic Information

Serial Number
85657232
Filing Date
June 20, 2012
Published for Opposition
November 13, 2012
Abandonment Date
August 10, 2015
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 10, 2015
Classes
005

Rights Holder

DENDREON PHARMACEUTICALS, INC.

03
Address
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER, NJ 08807

Ownership History

Dendreon Corporation

Original Applicant
03
Seattle, WA

Dendreon Corporation

Owner at Publication
03
Seattle, WA

DENDREON PHARMACEUTICALS, INC.

New Owner After Publication #1
03
BRIDGEWATER, NJ

Legal Representation

Attorney
Denis A. Polyn

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description Documents
Aug 10, 2015 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 10, 2015 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jul 29, 2015 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jul 15, 2015 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 20, 2015 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 20, 2015 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 7, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 6, 2015 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 24, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 24, 2014 EXT4 S SOU EXTENSION 4 FILED Loading...
May 30, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 29, 2014 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 23, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 23, 2014 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 28, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 27, 2014 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 24, 2014 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 6, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 6, 2013 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 6, 2013 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 16, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 14, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 14, 2013 EXT1 S SOU EXTENSION 1 FILED Loading...
May 14, 2013 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 8, 2013 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 13, 2012 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 13, 2012 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 24, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 4, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 4, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 28, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 23, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for use in the treatment of cancer, infections and autoimmune diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005